P-Glycoprotein Transport of Neurotoxic Pesticides.
P-glycoprotein (P-gp) has been associated with a number of neurodegenerative diseases, including Parkinson's disease, although the mechanisms remain unclear. Altered transport of neurotoxic pesticides has been proposed in Parkinson's disease, but it is unknown whether these pesticides are P-gp substrates. We used three in vitro transport models, stimulation of ATPase activity, xenobiotic-induced cytotoxicity, and inhibition of rhodamine-123 efflux, to evaluate P-gp transport of diazinon, dieldrin, endosulfan, ivermectin, maneb, 1-methyl-4-phenyl-4-phenylpyridinium ion (MPP(+)), and rotenone. Diazinon and rotenone stimulated ATPase activity in P-gp-expressing membranes, with Vmax values of 22.4 ± 2.1 and 16.8 ± 1.0 nmol inorganic phosphate/min per mg protein, respectively, and Km values of 9.72 ± 3.91 and 1.62 ± 0.51 µM, respectively, compared with the P-gp substrate verapamil, with a Vmax of 20.8 ± 0.7 nmol inorganic phosphate/min per mg protein and Km of 0.871 ± 0.172 μM. None of the other pesticides stimulated ATPase activity. We observed an increased resistance to MPP(+) and rotenone in LLC-MDR1-WT cells compared with LLC-vector cells, with 15.4- and 2.2-fold increases in EC50 values, respectively. The resistance was reversed in the presence of the P-gp inhibitor verapamil. None of the other pesticides displayed differential cytotoxicity. Ivermectin was the only pesticide to inhibit P-gp transport of rhodamine-123, with an IC50 of 0.249 ± 0.048 μM. Our data demonstrate that dieldrin, endosulfan, and maneb are not P-gp substrates or inhibitors. We identified diazinon, MPP(+), and rotenone as P-gp substrates, although further investigation is needed to understand the role of P-gp transport in their disposition in vivo and associations with Parkinson's disease.
Department of Biomedical and Pharmaceutical Sciences (S.E.L., K.S., J.V., R.D., E.L.W.), Center for Environmental Health Sciences (S.E.L.), and Center for Biomolecular Structure and Dynamics, University of Montana, Missoula, Montana (E.L.W.).
Sarah E
SE
Lacher
Department of Biomedical and Pharmaceutical Sciences (S.E.L., K.S., J.V., R.D., E.L.W.), Center for Environmental Health Sciences (S.E.L.), and Center for Biomolecular Structure and Dynamics, University of Montana, Missoula, Montana (E.L.W.).
Kasse
K
Skagen
Department of Biomedical and Pharmaceutical Sciences (S.E.L., K.S., J.V., R.D., E.L.W.), Center for Environmental Health Sciences (S.E.L.), and Center for Biomolecular Structure and Dynamics, University of Montana, Missoula, Montana (E.L.W.).
Joachim
J
Veit
Department of Biomedical and Pharmaceutical Sciences (S.E.L., K.S., J.V., R.D., E.L.W.), Center for Environmental Health Sciences (S.E.L.), and Center for Biomolecular Structure and Dynamics, University of Montana, Missoula, Montana (E.L.W.).
Rachel
R
Dalton
Department of Biomedical and Pharmaceutical Sciences (S.E.L., K.S., J.V., R.D., E.L.W.), Center for Environmental Health Sciences (S.E.L.), and Center for Biomolecular Structure and Dynamics, University of Montana, Missoula, Montana (E.L.W.) erica.woodahl@umontana.edu.
Erica L
EL
Woodahl
D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1 / Q000378:metabolism*; D001692:Biological Transport; D002460:Cell Line; D002462:Cell Membrane / Q000378:metabolism; D009498:Neurotoxins / Q000378:metabolism*; D010300:Parkinson Disease / Q000378:metabolism; D010575:Pesticides / Q000378:metabolism*
D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1; D009498:Neurotoxins; D010575:Pesticides